---
title: "Mikaela Naylon Give Kids a Chance Act"
identifier: "119-HR-1262"
congress: 119
bill_number: 1262
bill_type: "HR"
version_code: "eh"
version_type: "Engrossed in House"
bill_url: "https://chamberzero.com/congresses/119/bills/hr/1262"
source: "https://www.congress.gov/bill/119th-congress/house-bill/1262"
other_versions:
  - { code: "rh", type: "Reported in House", date: "2025-10-31", url: "https://chamberzero.com/congresses/119/bills/hr/1262/text.md?version=rh" }
  - { code: "ih", type: "Introduced in House", date: "2025-02-12", url: "https://chamberzero.com/congresses/119/bills/hr/1262/text.md?version=ih" }
site: "Chamber Zero"
site_url: "https://chamberzero.com"
rendered_at: "2026-06-04T00:32:28.343Z"
---
# Full Text Index

Full inline text is not available for this bill version in the current text index, but the section-level markdown is available below.

- [SECTION 1 Short title; table of contents](/congresses/119/bills/hr/1262/sections/1-section-one.md)
- [SECTION 2 Research into pediatric uses of drugs; additional authorities of Food and Drug Administration regarding molecularly targeted cancer drugs](/congresses/119/bills/hr/1262/sections/2.md)
- [SECTION 3 Ensuring completion of pediatric study requirements](/congresses/119/bills/hr/1262/sections/3.md)
- [SECTION 4 FDA report on PREA enforcement](/congresses/119/bills/hr/1262/sections/4.md)
- [SECTION 5 Extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases](/congresses/119/bills/hr/1262/sections/5.md)
- [SECTION 6 Limitations on exclusive approval or licensure of orphan drugs](/congresses/119/bills/hr/1262/sections/6.md)
- [SECTION 7 Program for pediatric studies of drugs](/congresses/119/bills/hr/1262/sections/7.md)
- [SECTION 8 Organ Procurement and Transplantation Network](/congresses/119/bills/hr/1262/sections/8.md)
- [SECTION 9 Establishment of Abraham Accords Office within Food and Drug Administration](/congresses/119/bills/hr/1262/sections/9.md)
- [SECTION 10 Increasing transparency in generic drug applications](/congresses/119/bills/hr/1262/sections/10.md)
- [SECTION 11 Medicare Improvement Fund](/congresses/119/bills/hr/1262/sections/11.md)